Nuvonyx Stock Performance
| TFGL Stock | USD 0.26 0.00 0.00% |
The company secures a Beta (Market Risk) of 0.89, which conveys possible diversification benefits within a given portfolio. Nuvonyx returns are very sensitive to returns on the market. As the market goes up or down, Nuvonyx is expected to follow. At this point, Nuvonyx has a negative expected return of -0.78%. Please make sure to verify Nuvonyx's risk adjusted performance, variance, as well as the relationship between the Variance and kurtosis , to decide if Nuvonyx performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Nuvonyx has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's technical and fundamental indicators remain quite persistent which may send shares a bit higher in January 2026. The latest mess may also be a sign of long-standing up-swing for the company institutional investors. ...more
Nuvonyx |
Nuvonyx Relative Risk vs. Return Landscape
If you would invest 51.00 in Nuvonyx on September 28, 2025 and sell it today you would lose (25.00) from holding Nuvonyx or give up 49.02% of portfolio value over 90 days. Nuvonyx is currently does not generate positive expected returns and assumes 6.1759% risk (volatility on return distribution) over the 90 days horizon. In different words, 55% of pink sheets are less volatile than Nuvonyx, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Nuvonyx Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nuvonyx's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Nuvonyx, and traders can use it to determine the average amount a Nuvonyx's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.126
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | TFGL |
Based on monthly moving average Nuvonyx is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nuvonyx by adding Nuvonyx to a well-diversified portfolio.
Nuvonyx Fundamentals Growth
Nuvonyx Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Nuvonyx, and Nuvonyx fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Nuvonyx Pink Sheet performance.
| Return On Equity | -14.9 | |||
| Return On Asset | -0.71 | |||
| Profit Margin | (1.72) % | |||
| Operating Margin | (1.64) % | |||
| Current Valuation | 1.4 M | |||
| Shares Outstanding | 1.77 M | |||
| Price To Earning | (0.18) X | |||
| Price To Sales | 0.53 X | |||
| Revenue | 1.5 M | |||
| EBITDA | (2.41 M) | |||
| Cash And Equivalents | 3.65 K | |||
| Book Value Per Share | (0.95) X | |||
| Cash Flow From Operations | (1.15 M) | |||
| Earnings Per Share | (1.91) X | |||
| Total Asset | 3.73 M | |||
About Nuvonyx Performance
By examining Nuvonyx's fundamental ratios, stakeholders can obtain critical insights into Nuvonyx's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Nuvonyx is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Tracker Financial Group Ltd engages in the manufacture and marketing of nutritional products that feature aloe vera juice as an ingredient. Tracker Financial Group Ltd was incorporated in 2007 and is based in Las Vegas, Nevada. Tracker Financial is traded on OTC Exchange in the United States.Things to note about Nuvonyx performance evaluation
Checking the ongoing alerts about Nuvonyx for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Nuvonyx help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Nuvonyx generated a negative expected return over the last 90 days | |
| Nuvonyx has high historical volatility and very poor performance | |
| Nuvonyx has some characteristics of a very speculative penny stock | |
| Nuvonyx has high likelihood to experience some financial distress in the next 2 years | |
| The company has a current ratio of 0.48, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Nuvonyx until it has trouble settling it off, either with new capital or with free cash flow. So, Nuvonyx's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nuvonyx sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nuvonyx to invest in growth at high rates of return. When we think about Nuvonyx's use of debt, we should always consider it together with cash and equity. | |
| Nuvonyx reported the previous year's revenue of 1.5 M. Net Loss for the year was (2.58 M) with loss before overhead, payroll, taxes, and interest of (465.52 K). | |
| Nuvonyx currently holds about 3.65 K in cash with (1.15 M) of positive cash flow from operations. |
- Analyzing Nuvonyx's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Nuvonyx's stock is overvalued or undervalued compared to its peers.
- Examining Nuvonyx's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Nuvonyx's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Nuvonyx's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Nuvonyx's pink sheet. These opinions can provide insight into Nuvonyx's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Nuvonyx Pink Sheet
Nuvonyx financial ratios help investors to determine whether Nuvonyx Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nuvonyx with respect to the benefits of owning Nuvonyx security.